A comparison of three scales for assessing social functioning in primary care

被引:107
作者
Weissman, MM
Olfson, M
Gameroff, MJ
Feder, A
Fuentes, M
机构
[1] New York State Psychiat Inst, Unit 24, Div Clin & Genet Epidemiol, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY USA
[3] Montclair State Univ, Dept Psychol, Upper Montclair, NJ 07043 USA
关键词
D O I
10.1176/appi.ajp.158.3.460
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Assessment of functional status is increasingly important in clinical trials and outcome research. Although several scares for assessing functioning are widely used, they vary in coverage, and di rea com parisons among them are rare. Comparative information is useful in guiding selection of appropriate scales for research applications. Method: Results from three scales that measure functioning-the Medical Outcomes Study 36-item Short-Form Health Survey, the Social Adjustment Scale Self-Report, and the Social Adaptation Self-Evaluation Scale-were compared in a consecutively selected sample of 211 patients coming to primary care. Patients also received psychiatric assessments. Results: All three scales were acceptable to patients, showed few significant correlations with demographic variables, and were able to differentiate psychiatrically ill and well patients. Correlations among scales, even among scale items that assessed similar domains of functioning, were modest. Conclusions: Although all three scales are presumed to assess functional status, their item content a nd coverage differ. Selection of a scale requires a review of the scale items and consideration of research priorities and the characteristics of the study group. If functional status is a critical outcome measure, use of more than one scale may be necessary.
引用
收藏
页码:460 / 466
页数:7
相关论文
共 25 条
[1]  
Beckman HT, 1997, J CLIN PSYCHOL, V53, P785, DOI 10.1002/(SICI)1097-4679(199712)53:8<785::AID-JCLP1>3.0.CO
[2]  
2-F
[3]   Development and validation of a social functioning scale, the social adaptation self-evaluation scale [J].
Bosc, M ;
Dubini, A ;
Polin, V .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 :S57-S70
[4]   Assessment of social functioning in depression [J].
Bosc, M .
COMPREHENSIVE PSYCHIATRY, 2000, 41 (01) :63-69
[5]   DEPRESSION, DISABILITY DAYS, AND DAYS LOST FROM WORK IN A PROSPECTIVE EPIDEMIOLOGIC SURVEY [J].
BROADHEAD, WE ;
BLAZER, DG ;
GEORGE, LK ;
CHIU, KT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (19) :2524-2528
[6]  
Dubini A, 1997, J PSYCHOPHARMACOL, V11, pS17
[7]   Do noradrenaline and serotonin differentially affect social motivation and behaviour? [J].
Dubini, A ;
Bosc, M ;
Polin, V .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 :S49-S55
[8]  
GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405
[9]   The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing? [J].
Healy, D ;
Healy, H .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 51 (03) :313-322
[10]  
*ICIDH, 1980, INT CLASS IMP DIS HA